Pleiotropy GWAS of Alzheimer's Disease
阿尔茨海默病的多效性 GWAS
基本信息
- 批准号:9349452
- 负责人:
- 金额:$ 41.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAlzheimer&aposs DiseaseAmyloid beta-ProteinAmyotrophic Lateral SclerosisArchivesBiologicalBiological MarkersBrainCandidate Disease GeneCase-Control StudiesCohort StudiesCollectionDataData AnalysesData SetDevelopmentDiseaseEnhancersEthnic groupEventFrontotemporal DementiaGenesGeneticGenetic studyGenomicsGenotypeGenotype-Tissue Expression ProjectGoalsHaplotypesHeritabilityIndividualInflammationKnowledgeLewy Body DementiaMental DepressionMeta-AnalysisMethodsNational Institute on AgingNerve DegenerationNeurodegenerative DisordersNeurofibrillary TanglesParkinson DiseasePathologicPathologyPathway AnalysisPathway interactionsPersonsPhenotypeProcessProgressive Supranuclear PalsyProspective cohort studyProteinsProtocols documentationResearch PersonnelResourcesRiskRisk FactorsSchizophreniaStructureTREM2 geneTestingTimeUnited States National Institutes of HealthValidationVariantWorkalpha synucleinbasecase controlcohortdata resourcedatabase of Genotypes and Phenotypesendophenotypeexomeexome sequencingexperiencefunctional genomicsgenetic associationgenetic risk factorgenetic variantgenome wide association studygenome-widegenomic datahyperphosphorylated tauimprovedinterestlongitudinal analysisneurodegenerative phenotypeneuropsychiatric disordernovelonline resourcephenotypic datapleiotropismprotein aggregationrare varianttau Proteinstau aggregationtherapeutic targettraitwhole genome
项目摘要
PROJECT SUMMARY
This proposal, entitled “Pleiotropy GWAS of Alzheimer's Disease and Multiple Neurodegenerative Diseases,”
describes plans to analyze existing neurodegenerative phenotype and genome-wide genotype data from
existing genome-wide association studies (GWAS) of multiple neurodegenerative diseases, including
Alzheimer's disease (AD), Parkinson's disease (PD), and frontotemporal dementia (FTD), among others. While
neurodegenerative diseases have distinct pathologies, there are also shared pathological features like protein
aggregation in the brain (e.g., tau protein). This suggests that genetic studies combining neurodegenerative
disease genetics studies may identify genetic risk factors contributing to one or more individual NDs
(“pleiotropy”) through these common features. The goal of these planned analyses is to identify genetic loci
and variants with effects across multiple NDs. Our approach includes broad hypothesis-free analyses like
GWAS meta-analysis, as well as targeted “drill-down” approaches like pathway analyses examining known
biological pathways. These analyses will use publicly available data on genome-wide association study and
whole genome/exome sequence datasets curated by individual groups, disease-specific consortia, and on the
NIH Database of Genotypes and Phenotypes (dbGaP). This project will require extensive collection of
genotypes from well-characterized cases and controls; systematic archiving of case-control and prospective
cohort studies; a formally-structured data harmonization process; inclusion of multiethnic GWAS and
WGS/WES studies; and longitudinal analyses in cohort studies of neurodegeneration in order to fulfill the
mandate of the National Institute on Aging (NIA) RFA PAR-15-356. Our three aims include (1) harmonization
and integration of genotype and phenotype data from multiple large-scale genetic studies of differeing
neurodegenerative diseases; (2) estimating shared heritability between neurodegenerative diseases and
performing GWAS and WGS/WES association study meta-analyses; and (3) performing analyses of
intermediate and related phenotypes and incorporating functional annotation to identify truly functional
pleiotropic variants and their causal effects on multiple neurodegenerative diseases. These analyses will
examine both common and rare genomic variants and will use a similar strategy to existing genetic studies
comparing neuropsychiatric disorders (e.g, schizophrenia, depression), with refinement and development of
novel pleiotropy methods. We will leverage our considerable experience with large-scale genetic association
and meta-analysis studies to identify new genetic risk factors for neurodegenerative diseases using data on
tens of thousands of affected and unaffected individuals. Furthermore, we will create an online resource for
data harmonization and sharing analysis results with investigators interested in shared genetic risk factors of
neurodegeneration.
项目摘要
该提案,标题为“阿尔茨海默氏病和多种神经退行性疾病的多效性GWA”,
描述了分析现有神经退行性表型和全基因组基因型数据数据的计划
现有的全基因组关联研究(GWAS)多种神经退行性疾病,包括
阿尔茨海默氏病(AD),帕金森氏病(PD)和额叶痴呆症(FTD)等。
神经退行性疾病具有不同的病理,也有共同的病理特征,例如蛋白质
大脑中的聚集(例如,tau蛋白)。这表明结合神经退行性的遗传研究
疾病遗传学研究可能鉴定出造成一个或多个个人ND的遗传危险因素
(“多效性”)通过这些共同特征。这些计划分析的目的是确定遗传基因座
以及在多个ND的效果的变体。我们的方法包括广泛的假设分析
GWAS荟萃分析,以及针对性的“钻井”方法,例如检查已知的途径
生物途径。这些分析将使用全基因组协会研究中的公开数据和
由个别群体,疾病特异性财团和在
NIH基因型和表型(DBGAP)的数据库。该项目将需要大量收集
来自特征良好的病例和对照的基因型;案例对照和预期的系统归档
队列研究;正式结构的数据协调过程;包括多民族GWA和
WGS/WES研究;以及神经退行性研究的队列研究中的纵向分析,以实现
国家老化研究所(NIA)RFA PAR-15-356的任务。我们的三个目标包括(1)协调
以及来自多个不同大规模遗传研究的基因型和表型数据的整合
神经退行性疾病; (2)估计神经退行性疾病和
进行GWAS和WGS/WES协会研究荟萃分析; (3)进行分析
中间和相关表型和合并功能注释,以识别真正的功能
多效变体及其因果对多种神经退行性疾病的影响。这些分析将
检查常见和罕见的基因组变体,并将使用与现有遗传研究类似的策略
比较神经精神疾病(例如精神分裂症,抑郁症),并进行完善和发展
新型多效方法。我们将利用大规模遗传关联的考虑经验
和荟萃分析研究,以鉴定神经退行性疾病的新遗传危险因素使用有关
成千上万的受影响和未受影响的人。此外,我们将为
与对共享遗传风险因素感兴趣的调查人员的数据协调和共享分析结果
神经变性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adam Christian Naj其他文献
Adam Christian Naj的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adam Christian Naj', 18)}}的其他基金
Core C- Biostatistics and Data Analysis Core
核心C-生物统计和数据分析核心
- 批准号:
10388087 - 财政年份:2016
- 资助金额:
$ 41.13万 - 项目类别:
Core C- Biostatistics and Data Analysis Core
核心C-生物统计和数据分析核心
- 批准号:
10604373 - 财政年份:2016
- 资助金额:
$ 41.13万 - 项目类别:
Core C- Biostatistics and Data Analysis Core
核心C-生物统计和数据分析核心
- 批准号:
10090893 - 财政年份:2016
- 资助金额:
$ 41.13万 - 项目类别:
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 41.13万 - 项目类别:
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 41.13万 - 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 41.13万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 41.13万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 41.13万 - 项目类别: